Article Information
History
- December 14, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Nick Andrews, PhD1,2,
- Julia Stowe, PhD1,
- Freja Kirsebom, PhD1,
- Samuel Toffa, PhD1,
- Tim Rickeard1,
- Eileen Gallagher, PhD1,
- Charlotte Gower, DPhil1,
- Meaghan Kall1,
- Natalie Groves, MSc1,
- Anne-Marie O’Connell1,
- David Simons1,
- Paula B. Blomquist1,
- Asad Zaidi1,
- Sophie Nash1,
- Nurin Iwani Binti Abdul Aziz1,
- Simon Thelwall1,
- Gavin Dabrera, MBBS, FFPH1,
- Richard Myers, MRCPCH1,3,
- Gayatri Amirthalingam, MFPH1,2,
- Saheer Gharbia1,
- Jeffrey C. Barrett, D Phil4,
- Richard Elson1,
- Shamez N Ladhani, PhD, MRCPCH1,3,
- Neil Ferguson5,6,
- Maria Zambon, PhD, FRCPath1,6,
- Colin NJ Campbell, MPH, FFPH1,2,
- Kevin Brown, MRCP FRCPath1,2,
- Susan Hopkins, FRCP, FFPH1,7,
- Meera Chand, MRCP, FRCPath1,8,
- Mary Ramsay, MBBS, FFPH1,2 and
- Jamie Lopez Bernal, PhD, MBBS1,2,6,*
- 1UK Health Security Agency, London, United Kingdom
- 2NIHR Health Protection Research Unit in Vaccines and Immunisation, London School of Hygiene and Tropical Medicine, London, United Kingdom
- 3Paediatric Infectious Diseases Research Group (PIDRG), St George’s University of London, London, United Kingdom
- 4Wellcome Sanger Institute, Hinxton, UK
- 5MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK
- 6NIHR Health Protection Research Unit in Respiratory Infections, Imperial College London, United Kingdom
- 7Healthcare Associated Infections and Antimicrobial Resistance, University of Oxford, Oxford, UK
- 8Guys and St Thomas’s Hospital NHS Trust, London, UK
- ↵*Corresponding author; email: jamie.lopezbernal2{at}phe.gov.uk
Posted December 14, 2021.
Effectiveness of COVID-19 vaccines against the Omicron (B.1.1.529) variant of concern
